Valuation: Maravai LifeSciences Holdings, Inc.

Market Cap 919M 795M 742M 681M 1.28B 87.46B 1.3B 8.71B 3.42B 43.84B 3.45B 3.38B 145B P/E 2026 *
-27.1x
P/E 2027 * -19.9x
Enterprise Value 919M 795M 743M 681M 1.28B 87.51B 1.3B 8.71B 3.42B 43.86B 3.45B 3.38B 145B EV / Sales 2026 *
4.35x
EV / Sales 2027 * 3.86x
Free-Float
41.47%
Yield 2026 *
-
Yield 2027 * -
1 day-0.32%
1 week-5.18%
Current month-5.18%
1 month+5.24%
3 months+58.12%
6 months+98.41%
Current year+91.69%
1 week 5.41
Extreme 5.41
6.65
1 month 5.41
Extreme 5.41
7.44
Current year 2.8
Extreme 2.8
7.44
1 year 2.02
Extreme 2.025
7.44
3 years 1.66
Extreme 1.665
11.56
5 years 1.66
Extreme 1.665
63.55
10 years 1.66
Extreme 1.665
63.55
Manager TitleAgeSince
Chief Executive Officer 59 2025-06-07
Director of Finance/CFO 59 2025-06-29
Chief Operating Officer - 2025-07-31
Director TitleAgeSince
Director/Board Member 50 2016-02-29
Director/Board Member 65 2020-10-31
Director/Board Member 61 2019-12-31
Date Insider Type Main position Quantity % Market Cap.
7/30/26 Tax

Chief Financial Officer

-5,465 0.0037%
7/8/26 Tax

Chief Executive Officer

-29,250 0.0198%
6/30/26 Tax

Chief Financial Officer

-65,584 0.0445%
Change 5-day change 1-year change 3-year change Capi.($)
-0.32%-5.18%+207.65%-43.47% 919M
+5.64%+10.46%+98.80%+272.09% 3.98B
+2.32%+1.94%+70.59%+90.48% 3.8B
+2.09%+55.77%+140.15%-10.07% 2.87B
+4.20%+6.82%+286.83%+332.31% 2.42B
+4.99%+4.72%-25.28%-32.77% 2.27B
+2.20%0.00%+5.49% - 1.26B
+0.70%+7.43%-3.67%+25.65% 934M
+3.09%+3.92%-37.86%-5.07% 532M
-1.90%+9.72%+2.62% - 503M
Average +2.30%+9.36%+74.53%+78.64% 1.95B
Weighted average by Cap. +3.21%+12.66%+96.22%+118.89%

Financials

2026 *2027 *
Net sales 211M 183M 171M 157M 294M 20.1B 299M 2B 786M 10.08B 793M 776M 33.31B 225M 195M 182M 167M 314M 21.44B 319M 2.14B 838M 10.75B 846M 828M 35.53B
Net income -53.42M -46.21M -43.15M -39.58M -74.45M -5.08B -75.64M -506M -199M -2.55B -201M -196M -8.42B -49.14M -42.51M -39.7M -36.41M -68.49M -4.68B -69.58M -466M -183M -2.34B -185M -180M -7.75B
Net Debt 525K 454K 424K 389K 732K 49.98M 744K 4.98M 1.95M 25.05M 1.97M 1.93M 82.82M -49.97M -43.23M -40.37M -37.03M -69.65M -4.76B -70.76M -474M -186M -2.38B -188M -184M -7.88B
Logo Maravai LifeSciences Holdings, Inc.
Maravai LifeSciences Holdings, Inc. is a life sciences company providing critical products and services to enable the development of drugs, therapeutics, vaccines, and diagnostics, and support research on human disease. Its segments include TriLink and Cygnus. Its TriLink segment provides nucleic acid products and related services, including messenger ribonucleic acid (mRNA), oligonucleotides, CleanCap mRNA capping technology, ModTail poly(A) tail modification technology, synthesis inputs, nucleoside triphosphates, enzymes, and mRNA manufacturing services. Its Cygnus segment provides biologics safety testing products and services, including host cell protein enzyme-linked immunosorbent assay (ELISA) kits, impurity detection assays, viral clearance prediction tools, ancillary reagents, and custom analytical services. Its TriLink and Cygnus segments produce materials used in research and biopharmaceutical production, clinical trial vaccines and vaccine support products.
Employees
416
Date Price Change Volume
26-08-07 US$6.230 -0.32% 4,077,591
26-08-06 US$6.250 -2.50% 1,473,449
26-08-05 US$6.410 -0.31% 1,199,450
26-08-04 US$6.430 +0.16% 1,608,554
26-08-03 US$6.420 -2.28% 2,047,047
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
6.230USD
Average target price
7.100USD
Spread / Average Target
+13.96%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MRVI Stock